Peer Review reports
From: Repurposing existing drugs for COVID-19: an endocrinology perspective
| Original Submission | ||
|---|---|---|
| 16 Jun 2020 | Submitted | Original manuscript |
| 3 Jul 2020 | Reviewed | Reviewer Report |
| 17 Jul 2020 | Reviewed | Reviewer Report |
| 27 Jul 2020 | Author responded | Author comments - Flavio Cadegiani |
| Resubmission - Version 2 | ||
| 27 Jul 2020 | Submitted | Manuscript version 2 |
| 26 Aug 2020 | Author responded | Author comments - Flavio Cadegiani |
| Resubmission - Version 3 | ||
| 26 Aug 2020 | Submitted | Manuscript version 3 |
| 8 Sep 2020 | Author responded | Author comments - Flavio Cadegiani |
| Resubmission - Version 4 | ||
| 8 Sep 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 14 Sep 2020 | Editorially accepted | |
| 29 Sep 2020 | Article published | 10.1186/s12902-020-00626-0 |
You can find further information about peer review here.